Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;33(6):1124-1132.
doi: 10.1111/jdv.15475. Epub 2019 Apr 8.

Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczema

L Howells  1 , K S Thomas  1 , A V Sears  2   3 , I Nasr  4 , A Wollenberg  5   6 , M L A Schuttelaar  7 , G L E Romeijn  7 , A S Paller  8 , K Mueller  8 , K Doytcheva  8 , Y Kataoka  9 , J Daguze  10 , S Barbarot  10 , L B von Kobyletzki  11 , L Beckman  12 , S Ratib  1 , F Cowdell  13 , M Santer  14 , J R Chalmers  1 ; long-term control of eczema working group for the HOME initiative
Affiliations

Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczema

L Howells et al. J Eur Acad Dermatol Venereol. 2019 Jun.

Abstract

Background: Atopic eczema (also known as eczema) is a chronic, inflammatory skin condition that often afflicts patients' health and well-being. The Harmonising Outcome Measures for Eczema (HOME) initiative recommends that 'long-term control of eczema' is measured in all clinical trials 3 months or longer in duration. However, little has been published on what eczema control means to those living with or treating atopic eczema.

Objectives: To (i) develop understanding of what eczema control means to patients, carers and clinicians and (ii) explore the feasibility and acceptability of different ways of measuring eczema control in the long term.

Methods: Online focus groups explored patients/carers experiences in the UK, the United States, the Netherlands, France, Sweden and Japan, and an international online survey gathered views of clinicians. The framework method was used to analyse the focus groups, and thematic analysis was used to analyse survey data. All findings were integrated into a theoretical framework to create overarching themes that cut across these diverse groups.

Results: Eight focus groups with patients (16 years+) and eight groups with carers of children took place (N = 97). Sixty-two people took part in the survey. Eczema control was described as a multifaceted construct involving changes in disease activity, the treatment and management of the condition and psychological, social and physical functioning. Patient/carer measurement allows personal accounts and frequent measurement, whilst clinician measurement was deemed less subjective. The burden on patients/carers and issues for analysing and interpreting data should be considered.

Conclusions: This study formed the basis of judging the content validity and feasibility of measurement instruments/methods to assess control of eczema in clinical trials. This online approach to an international qualitative study is an example of how core outcome set developers with limited resources can engage with multiple stakeholder groups on an international basis to inform consensus meeting discussions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Country of residence for online survey respondents.
Figure 2
Figure 2
What does atopic eczema control mean to patients, parents and clinicians?
See this image and copyright information in PMC

References

    1. Schofield J, Grindlay D, Williams H. Skin Conditions in the UK: A Health Care Needs Assessment. University of Nottingham, Nottingham, UK, 2009.
    1. Zuberbier T, Orlow SJ, Paller AS et al Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol 2006; 118: 226–232. - PubMed
    1. Schmitt J, Spuls P, Boers M et al Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy 2012; 67: 1111–1117. - PubMed
    1. Schmitt J, Williams H. Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol, 2010; 163: 1166–1168. - PubMed
    1. Chalmers JR, Simpson E, Apfelbacher CJ et al Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol 2016; 175: 69–79. - PubMed